Oncotool for Cancer Medications

Clinical trial NCT03952312 · COMPLETED

Trial details

NCT number: NCT03952312
Sponsor: Northwestern University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer Cancer, Treatment-Related Medication Adherence Communication Tyrosine Kinase Inhibitor

Start date: 2020-01-15
Primary completion: 2022-08-13
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.